✦ LIBER ✦

420 Increased Clearance of Docetaxel in Androgen Deprived Prostate Cancer Patients

✍ Scribed by Nieuweboer, A.J.M.; de Graan, A.J.; de Jonge, M.J.A.; de Bruijn, P.; Friberg, L.E.; van Doorn, L.; Wiemer, E.A.C.; de Wit, R.; Mathijssen, R.H.

Book ID: 122438923
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72218-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel + estramustine + androgen depr

Docetaxel + estramustine + androgen deprivation in prostate cancer

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Increase of bone alkaline phosphatase af

Increase of bone alkaline phosphatase after androgen deprivation therapy in patients with prostate cancer

✍ Juan Morote; Youssef I.D M’Hammed; Esther Martinez; Salvador Esquena; Jose Anton 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Androgen Deprivation Therapy in Patients

Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer

✍ Robert Dreicer 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 112 KB

Reversibility of androgen deprivation th

Reversibility of androgen deprivation therapy in patients with prostate cancer

✍ A. Fridmans; B. Chertin; I. Spitz; A. Farkas 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 203 KB

REVERSIBILITY OF ANDROGEN DEPRIVATION TH

REVERSIBILITY OF ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER

✍ FRIDMANS, A; CHERTIN, B; KOULIKOV, D; LINDENBERG, T; GELBER, H; LEITER, C; FARKA 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 336 KB

Androgen deprivation therapy increases c

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

✍ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec